Skip to main content
Summary
Profile
Financials
Events
Ownership
Options

Company Info

Industry Biotechnology
Sector Health Technology
Employees 8
CEO Dr. Pnina Fishman
Address 10 Bareket Street Kiryat Matalon, Petach Tikva, HM 49170
Phone 972.3.924.1114
Website www.canfite.com

Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for cancer and inflammatory diseases. Its product pipeline includes Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.

Competitors

Company Name 3 Month
%Change
1 Year
%Change
Can-Fite BioPharma Ltd. -34.34% -35.97%
BellRing Brands, Inc. -23.22% 17.13%
ImmunoGen, Inc. -16.49% -7.74%
Heron Therapeutics, Inc. -18.03% -47.25%
Singular Genomics Systems, Inc. -23.64% n/a

Statement Summary

as of 1:10 ET PM 11/26/2021
Total Assets (MRQ) 9.7 M
Total Liabilities (MRQ) 5.7 M
Shareholders’ Equity (MRQ) 4.0 M
Total Revenue (Annual) 250.0 K
Net Income (Annual) -3.2 M

Earnings And Estimates

as of 1:10 ET PM 11/26/2021

Current Qtr EPS Estimate -0.06
Current FY EPS Estimate -0.34
Long Term EPS Growth Estimate 1.00
Next Expected Earnings Date //

CANF vs S&P 500

as of 11/26/2021
Relative To
S&P 500
CANF
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 1:10 ET PM 11/26/2021
Fiscal Quarter Estimate Actual Surprise
09/2021 -0.07 -0.07 0.00%
06/2021 -0.16 -0.12 -22.58%
03/2021 -0.14 0.00 -100.00%
12/2020 -0.14 -0.16 +18.52%
09/2020 -0.24 -0.16 -31.91%
06/2020 -0.25 -0.30 +19.99%
03/2020 -0.42 -0.90 +116.89%
12/2019 -0.89 0.00 -100.00%

Financial Strength

as of 1:10 ET PM 11/26/2021
Pre-Tax Margin -1.00
Net Margin 32.53
Operating Margin -1.00
Return On Equity -172.45
Return On Assets -100.58
Inventory Turnover (TTM) 0.00
Sales Growth (MRQ) 35.75

Ratios

as of 1:10 PM ET 11/26/2021
Price/Earnings (TTM) n/a
Price/Book (MRQ) 5.34
Price/Cash Flow (TTM) 0.00
Book Value (MRQ) 0.23
Quick Ratio (MRQ) 4.05
Current Ratio (MRQ) 4.05
Total Debt/Equity (MRQ) 0.02

Short Interest

as of 1:12 PM ET 11/29/2021
% Short - 0.00%
% Remaining Float - 100.00%
Current Last Month
Short Interest Date 11/15/2021 10/29/2021
Short Interest Shares 267,532 315,415
Short Interest Ratio 0.7 1.6
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00 0,0.00
Cash from
Activities
0,0.00 0,0.00
Cash from
Fin. Activities
0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Earnings Estimates

as of 1:10 ET PM 11/26/2021
Current Qtr
(12/2021)
Next Qtr
(03/2022)
Consensus Estimate $-0.06 $-0.09
# of Estimates 2 1
High Estimate $-0.04 $-0.09
Low Estimate $-0.08 $-0.09
Year Ago EPS $-0.12 $-0.19
Year Over Year Growth Estimate -48.45% -51.92%
Current Yr
(12/2021)
Next Yr
(12/2022)
Consensus Estimate $-0.34 $-0.30
# of Estimates 2 2
High Estimate $-0.22 $-0.20
Low Estimate $-0.45 $-0.40
Year Ago EPS $-1.20 $-0.34
Year Over Year Growth Estimate -72.09% -10.45%
Current Qtr
(12/2021)
Next Qtr
(03/2022)
Current Year
(12/2021)
Next Year
(12/2022)
Consensus Estimate $-0.06 $-0.09 $-0.34 $-0.30
# of Estimates 2 1 2 2
High Estimate $-0.04 $-0.09 $-0.22 $-0.20
Low Estimate $-0.08 $-0.09 $-0.45 $-0.40
Year Ago EPS $-0.12 $-0.19 $-1.20 $-0.34
Year Over Year Growth Estimate -48.45% -51.92% -72.09% -10.45%

Insider Information Summary

as of n/a
% Insiders - n/a
% Remaining Total Shares - n/a
Current 1 Month
Net Insider Transaction 0.00 0.00
Shares Bought 0.00 0.00
Shares Sold 0.00 0.00

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

LATEST NEWS

Recent Articles from TheStreet

Bill Ackman

Ackman: Omicron May Be Bullish for Stocks; El-Erian Less Sanguine

'While it is too early to have definitive data, early reported data suggest omicron virus causes mild to moderate symptoms,' Bill Ackman says.

Walmart Store Accountants

BofA: Walmart, Target 'Especially Well Positioned' for Holidays

The strength for Walmart and Target stems from 'their strong omni-channel execution ... and dominant scales,' BofA said.

Twitter Lead

Buy or Sell Twitter as Dorsey Steps Down as CEO?

Twitter shares spike higher, then collapse lower on Monday on news that CEO Jack Dorsey is stepping down. Here's the trade now.

Joe Biden Lead

Biden and Walmart, CVS CEOs to Meet on Supply Chain, Omicron Variant

A Monday call between Biden and top retail executives was to address bottlenecks created by supply shortages and the Omicron variant.

AMC Entertainment Lead

AMC, Sony Offer NFTs to Advance 'Spider-Man: No Way Home' Ticket Buyers

AMC's NFT offer for 'Spider-Man: No Way Home' causes online ticket traffic to soar to its highest level.

Covid-19 Vaccine Lead

'Vaccine' Chosen as Word of The Year

The 202I prize for Merriam-Webster’s Word of the Year went to an obvious choice: vaccine.

Stronger Yen Sends Nissan's Profits South

Nissan to Invest Over $17 Billion in EVs Over Next 5 Years

Nissan hopes to roll out 23 new electric vehicle models by 2030.

Patty Hearst NFT Lead

NFTs: Patty Hearst Court Drawing, USS Arizona Mapping to Be Auctioned

NFTs: A courtroom drawing from the trial of kidnapped heiress Patty Hearst and an illustrated mapping of the USS Arizona are up for auction.

Elon Musk, founder of Tesla and SpaceX, brought attention on the Clubhouse to new heights after hosting a conversation on the audio social app. Photo: AFP

Musk Urges Tesla Staff to Watch Costs, Keep Cool on Deliveries

'Our focus this quarter should be on minimizing cost of deliveries rather than spending heavily ... just so that cars arrive in Q4,' he said.

Cyber Monday Results Rolling In -- Here Are the Brands Facing Pressure

Cyber Monday Discounts Cut Due to Lean Inventories: Adobe

Consumers are expected to spend between $10.2 billion and $11.3 billion on Cyber Monday, Adobe said.